New injection targets double chin: embella tested in small trial
NCT ID NCT06509438
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study tested the safety and effectiveness of Embella (deoxycholic acid) injections for reducing submental fat, also known as a double chin. Twenty adults aged 18 to 65 with unwanted chin fat received injections and were followed for 3 months. The goal was to see if the treatment could improve fat grading and reduce fat thickness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Deoxycholic acid (injectable solution, brand name Embella)
- What this could lead to
- If it works, this could offer a non-surgical option to reduce chin fat and improve appearance.
- What could go wrong
- This is a small, completed trial with only 20 participants. Results may not apply to everyone, and side effects like pain or swelling are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBMENTAL FULLNESS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Center for Research and Training in Skin Diseases and Leprosy
Tehran, 1416613675, Iran
More trials for these conditions
Other studies related to the condition(s) this trial covers.